Cystitis primary prevention: Difference between revisions
Usama Talib (talk | contribs) Created page with "__NOTOC__ {{Cystitis}} {{CMG}} {{AE}} {{YD}}, {{USAMA}} ==Overview== Preventative measures to avoid cystitis include abstinence from sexual activity, voiding after intercourse..." |
Usama Talib (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Pyelonephritis}} | ||
{{CMG}} {{AE}} | {{CMG}} {{AE}} {{USAMA}} | ||
==Overview== | ==Overview== | ||
Preventative measures to avoid | Preventative measures to avoid Pyelonephritis include the measures for preventing a urinary tract infection which include voiding after intercourse, use of barrier contraception, increasing fluid intake and frequency of urination, and use of [[estrogen]] (among post-menopausal women). Single-dose prophylactic antimicrobial therapy prior to sexual intercourse may be administered to patients who have recurrent episodes of cystitis that are associated with sexual activity. Prevention of recurrence of cystitis may also be helpful in preventing development of pyelonephritis. | ||
==Primary Prevention== | ==Primary Prevention== | ||
The following preventative measures may reduce the risk of | The following preventative measures may reduce the risk of urinary tract infections which are an important cause of Pyelonephritis: | ||
<ref name="Raz-1993">{{Cite journal | last1 = Raz | first1 = R. | last2 = Stamm | first2 = WE. | title = A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. | journal = N Engl J Med | volume = 329 | issue = 11 | pages = 753-6 | month = Sep | year = 1993 | doi = 10.1056/NEJM199309093291102 | PMID = 8350884 }}</ref> | <ref name="Raz-1993">{{Cite journal | last1 = Raz | first1 = R. | last2 = Stamm | first2 = WE. | title = A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. | journal = N Engl J Med | volume = 329 | issue = 11 | pages = 753-6 | month = Sep | year = 1993 | doi = 10.1056/NEJM199309093291102 | PMID = 8350884 }}</ref> | ||
*Prevention of recurrence of [[cystitis]] | |||
*Abstinence from sexual activity | *Abstinence from sexual activity | ||
*Voiding after every intercourse | *Voiding after every intercourse | ||
| Line 14: | Line 15: | ||
*Use of topical estrogen among post-menopausal women | *Use of topical estrogen among post-menopausal women | ||
The use of cranberry to prevent cystitis remains controversial. Cranberry is thought to prevent the adherence of uropathogens to urothelial cells, but its benefit is yet to be proven.<ref>{{Cite journal |last1 = Hooton | first1 = TM. | title = Clinical practice. Uncomplicated urinary tract infection. | journal = N Engl J Med | volume = 366 | issue = 11 | pages = 1028-37 | month = Mar | year = 2012 |doi = 10.1056/NEJMcp1104429 | PMID = 22417256 }}</ref> | The use of cranberry to prevent cystitis and thus pyelonephritis remains controversial. Cranberry is thought to prevent the adherence of uropathogens to urothelial cells, but its benefit is yet to be proven.<ref>{{Cite journal |last1 = Hooton | first1 = TM. | title = Clinical practice. Uncomplicated urinary tract infection. | journal = N Engl J Med | volume = 366 | issue = 11 | pages = 1028-37 | month = Mar | year = 2012 |doi = 10.1056/NEJMcp1104429 | PMID = 22417256 }}</ref> | ||
==References== | ==References== | ||
Revision as of 20:35, 27 January 2017
|
Pyelonephritis Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cystitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Cystitis primary prevention |
|
Risk calculators and risk factors for Cystitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Overview
Preventative measures to avoid Pyelonephritis include the measures for preventing a urinary tract infection which include voiding after intercourse, use of barrier contraception, increasing fluid intake and frequency of urination, and use of estrogen (among post-menopausal women). Single-dose prophylactic antimicrobial therapy prior to sexual intercourse may be administered to patients who have recurrent episodes of cystitis that are associated with sexual activity. Prevention of recurrence of cystitis may also be helpful in preventing development of pyelonephritis.
Primary Prevention
The following preventative measures may reduce the risk of urinary tract infections which are an important cause of Pyelonephritis: [1]
- Prevention of recurrence of cystitis
- Abstinence from sexual activity
- Voiding after every intercourse
- Use barrier contraception and avoiding spermicides
- Increasing the intake of fluids and the frequency of urination
- Use of topical estrogen among post-menopausal women
The use of cranberry to prevent cystitis and thus pyelonephritis remains controversial. Cranberry is thought to prevent the adherence of uropathogens to urothelial cells, but its benefit is yet to be proven.[2]
References
- ↑ Raz, R.; Stamm, WE. (1993). "A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections". N Engl J Med. 329 (11): 753–6. doi:10.1056/NEJM199309093291102. PMID 8350884. Unknown parameter
|month=ignored (help) - ↑ Hooton, TM. (2012). "Clinical practice. Uncomplicated urinary tract infection". N Engl J Med. 366 (11): 1028–37. doi:10.1056/NEJMcp1104429. PMID 22417256. Unknown parameter
|month=ignored (help)